What amount sold does Pharmetrics Capital Partners, LLC report in Form D filings?

The latest linked filings report $140K sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Pharmetrics Capital Partners, LLC's most recent SEC filing?

Pharmetrics Capital Partners, LLC's most recent Form D filing was on 2015-02-13.

How many investors does Pharmetrics Capital Partners, LLC have?

The most recent Form D filing lists 16 investor(s).

What type of securities does Pharmetrics Capital Partners, LLC offer?

Pharmetrics Capital Partners, LLC's SEC Form D filings indicate equity offerings.

Pharmetrics Capital Partners, LLC

CIK: 0001605173·Pharmaceuticals·ST. PETERSBURG, FL·Limited Liability Company·Founded 2014

Reported Sold

$140,000

Total Filings

Identified Offerings

Last Filed

Feb 13, 2015

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pharmaceuticals industry

SEC EDGAR

Offering filing timeline

Feb 13, 2015Form D — New notice

Reported sold: $140,000 · Target: $350,000

Rule 506(b)·16 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

$1 - $1,000,000

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$140,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Kerry Nicklas

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Feb 13, 2015	New	$350,000	$140,000	16

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

GOA Therapeutics Corp

Pharmaceuticals

Offering target: $225,000,000

Filed Nov 5, 2026